BCWORLD PHARM. Co. Ltd Cash Flow-to-Debt Ratio
BCWORLD PHARM. Co. Ltd cash flow-to-debt ratio. BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩1.43 Billion could theoretically repay 0% of its total liabilities (₩101.30 Billion) in one year. Check BCWORLD PHARM. Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BCWORLD PHARM. Co. Ltd (2015–2024)
Cash flow-to-debt ratio of BCWORLD PHARM. Co. Ltd from 2015 to 2024. Historical debt coverage capacity for BCWORLD PHARM. Co. Ltd across 10 annual periods. Check earnings quality score of BCWORLD PHARM. Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
BCWORLD PHARM. Co. Ltd Cash Flow-to-Debt Ratio by Year (2015–2024)
BCWORLD PHARM. Co. Ltd cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for BCWORLD PHARM. Co. Ltd. For the full cash flow conversion analysis, see 200780 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | ₩4.04 Billion | ₩99.65 Billion | ▼ -62.0% |
| 2023 | 0.11x | ₩10.94 Billion | ₩102.47 Billion | ▲ +60.5% |
| 2022 | 0.07x | ₩6.88 Billion | ₩103.50 Billion | ▲ +1150.4% |
| 2021 | -0.01x | ₩-619.83 Million | ₩97.90 Billion | ▲ +89.5% |
| 2020 | -0.06x | ₩-5.50 Billion | ₩91.27 Billion | ▼ -137.6% |
| 2019 | 0.16x | ₩12.11 Billion | ₩75.53 Billion | ▲ +115.1% |
| 2018 | 0.07x | ₩5.34 Billion | ₩71.65 Billion | ▼ -65.0% |
| 2017 | 0.21x | ₩7.90 Billion | ₩37.11 Billion | ▲ +1869.4% |
| 2016 | 0.01x | ₩243.66 Million | ₩22.54 Billion | ▼ -98.5% |
| 2015 | 0.73x | ₩8.78 Billion | ₩11.96 Billion | — |